ALPHARMA US PHARMS
GenericsALPHARMA US PHARMS is a generic drug manufacturer focused on Dermatology, Respiratory.
ALPHARMA US PHARMS's Key Drugs
ALPHARMA US PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
ALPHARMA US PHARMS's Recent FDA Approvals
New NDA/BLA approvals for ALPHARMA US PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
ALPHARMA US PHARMS's Therapeutic Areas
ALPHARMA US PHARMS's approved drugs and pipeline span 2 therapeutic areas, led by Dermatology and Respiratory. Weighted by commercial stage — approved drugs count most, then late-stage trials.
ALPHARMA US PHARMS's Top Competitors
ALPHARMA US PHARMS's closest competitors by therapeutic-area and drug-target overlap include Bayer, APOTHECON, and PHARMACIA AND UPJOHN. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
ALPHARMA US PHARMS Pipeline Snapshot
Active clinical trials for ALPHARMA US PHARMS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1965-06-04
- Latest
- 2002-12-23
- Applications
- 61